John A Allen
Affiliations: | 2015- | University of Texas at Galveston Medical Branch |
Area:
GPCRs, Dopamine and Serotonin receptors, Drug Discovery, Neuropharmacology, Cellular Signaling, Biochemistry, Chemical BiologyWebsite:
https://www.utmb.edu/phtox/faculty-staff-students/faculty-and-staff/allen-john-aGoogle:
"https://scholar.google.com/citations?user=orSNEd0AAAAJ&hl=en"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Mark M. Rasenick | grad student | 2001-2007 | UIC College of Medicine |
| Bryan L. Roth | post-doc | 2008-2011 | University of North Carolina at Chapel Hill School of Medicine |
Children
Sign in to add trainee| Ryan E. Murphy | grad student | 2020- | University of Texas at Galveston Medical Branch |
| Ashley Nilson | grad student | 2017-2020 | University of Texas at Galveston Medical Branch |
| Hudson R. Smith | post-doc | 2023- | University of Texas at Galveston Medical Branch |
| Manish K. Jain | post-doc | 2016-2019 | University of Texas at Galveston Medical Branch |
| Daniel Felsing | post-doc | 2016-2021 | University of Texas at Galveston Medical Branch |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Murphy RE, Wang P, Ali S, et al. (2024) Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists. Journal of Medicinal Chemistry |
| Ali S, Wang P, Murphy RE, et al. (2024) Orphan GPR52 as an emerging neurotherapeutic target. Drug Discovery Today. 103922 |
| Bolinger AA, Frazier A, La JH, et al. (2023) Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target. Acs Chemical Neuroscience |
| Wang P, Felsing DE, Chen H, et al. (2022) Retraction of "Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists". Acs Medicinal Chemistry Letters. 13: 989 |
| Wang P, Felsing DE, Chen H, et al. (2020) Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior. Journal of Medicinal Chemistry |
| Land MA, Chapman HL, Davis-Reyes BD, et al. (2019) Serotonin 5-HT Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In Vitro. Scientific Reports. 9: 16737 |
| Felsing DE, Jain MK, Allen JA. (2019) Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics. Current Topics in Medicinal Chemistry. 19: 1365-1380 |
| Wang P, Felsing DE, Chen H, et al. (2019) Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists. Acs Medicinal Chemistry Letters. 10: 792-799 |
| Ye N, Li B, Mao Q, et al. (2018) Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target. Acs Chemical Neuroscience |
| Felsing DE, Anastasio NC, Miszkiel JM, et al. (2018) Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction. Plos One. 13: e0203137 |